Patrice Debré

Patrice Debré

Auto-generated profile, based on publicly available information

Patrice Debré

INSERM, UMR-S 945, F-75013 Paris, France

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2010 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
HFHugues Fausther-Bovendo
Hugues Fausther-Bovendo
VVVincent Vieillard
Vincent Vieillard
SSSandrine SAGAN
Sandrine SAGAN
GBGeorges Bismuth
Georges Bismuth
PDPatrice Debré
Patrice Debré
CD4+ T cell loss is central to HIV pathogenesis. In the initial weeks post-infection, the great majority of dying cells are uninfected CD4+ T cells. We previously showed that the 3S motif of HIV-1 gp41 induces surface expression of NKp44L, a cellular ligand for an activating NK receptor, on uninfected bystander CD4+ T cells, rendering them susceptible to autologous NK killing. However, the mechanism of the 3S mediated NKp44L surface expression on CD4+ T cells remains unknown. Here, using immunoprecipitation, ELISA and blocking antibodies, we demonstrate that the 3S motif of HIV-1 gp41 binds to gC1qR on CD4+ T cells. We also show that the 3S peptide and two endogenous gC1qR ligands, C1q and HK, each trigger the translocation of pre-existing NKp44L molecules through a signaling cascade that involves sequential activation of PI3K, NADPH oxidase and p190 RhoGAP, and TC10 inactivation. The involvement of PI3K and NADPH oxidase derives from 2D PAGE experiments and the use of PIP3 and H2O2 as well as small molecule inhibitors to respectively induce and inhibit NKp44L surface expression. Using plasmid encoding wild type or mutated form of p190 RhoGAP, we show that 3S mediated NKp44L surface expression on CD4+ T cells is dependent on p190 RhoGAP. Finally, the role of TC10 in NKp44L surface induction was demonstrated by measuring Rho protein activity following 3S stimulation and using RNA interference. Thus, our results identify gC1qR as a new receptor of HIV-gp41 and demonstrate the signaling cascade it triggers. These findings identify potential mechanisms that new therapeutic strategies could use to prevent the CD4+ T cell depletion during HIV infection and provide further evidence of a detrimental role played by NK cells in CD4+ T cell depletion during HIV-1 infection. HIV infected individuals suffer from a loss of CD4+ lymphocytes. Initially, dying CD4+ lymphocytes are mainly infected ones. Afterward, the great majority of dying CD4+ lymphocytes are uninfected. The cause of uninfected CD4+ lymphocyte death during HIV infection is still under debate. We previously showed that one of the HIV-1 envelop proteins, gp41, induces the expression of a stress molecule called NKp44L on the surface of uninfected CD4+ lymphocytes. Uninfected CD4+ lymphocytes expressing NKp44L are killed, in vitro and in vivo, by cells of the immune system called NK cells. In this report, we study the CD4+ lymphocyte's proteins involved in the expression of NKp44L. To do so, we used several techniques to identify interacting or differentially expressed proteins and to inhibit or monitor enzymes activity. We also induce NKp44L using the product of some of the proteins involved in NKp44L expression. We found that HIV-1 gp41 binds to its receptor gC1qR on CD4+ lymphocytes. This interaction respectively activates the PI3K, the NADPH oxidase and p190 RhoGAP which inactivates TC10. Using the obtained data we build a model of the protein cascade involved in NKp44L surface expression.

1 September 2013 in Cellular Immunology
Verified
Journal Article
Closed access
ABAgata Bialoszewska-Magnusson
Agata Bialoszewska-Magnusson
FBFlorence Baychelier
Florence Baychelier
JNJustyna Niderla-Bielińska
Justyna Niderla-Bielińska
ACAndrzej Czop
Andrzej Czop
PDPatrice Debré
Patrice Debré
JMJacek Malejczyk
Jacek Malejczyk

1 January 1991 in Leukemia & Lymphoma
Verified
Journal Article
Closed access
PDF file
ELEric Legac
Eric Legac
CCClaude Chastang
Claude Chastang
JBJacques-Louis Binet
Jacques-Louis Binet
AMAriane Michel
Ariane Michel
PDPatrice Debre
Patrice Debre
HMHélène Merle-Beral
Hélène Merle-Beral
Immunophenotypic analysis was performed in 53 cases of B chronic lymphocytic leukemia using a large panel of monoclonal antibodies recognizing B, T, activation and myeloid antigens. Our results showed four patterns of reactivity: (a) several molecules were constantly expressed: CD19, CD20, CD24, CD37, HLA-DR, mu heavy chain, CD5, CD23, B5, CD32; (b) one antigen, CD11b, was found in 50 to 80% of the cases; (c) some markers were detected in less than 50% of the cases: CD25, CD38, CD71, CD11a, c, CD14b-c; (d) CD2 and CD16 were never detected. From these results, a phenotypic classification in three groups has been proposed and these groups were correlated with the progression of the disease, mainly with the lymphocyte doubling time of less than one year. We hypothesized that the leukemia cells could be at various stages of differentiation and/or activation according to their expression of activation and myeloid markers.

31 May 2011 in Peptides
Verified
Journal Article
Closed access
SGStanislas Grassin-Delyle
Stanislas Grassin-Delyle
ABAmparo Buenestado
Amparo Buenestado
LVLaurent Vallat
Laurent Vallat
ENEmmanuel Naline
Emmanuel Naline
SMSirima Marx
Sirima Marx
HMHélène Merle-Béral
Hélène Merle-Béral

1 November 2000 in European Journal of Immunology
Verified
Journal Article
Closed access
PDF file
JHJulie Harriague
Julie Harriague
PDPatrice Debré
Patrice Debré
GBGeorges Bismuth
Georges Bismuth
PHPascale Hubert
Pascale Hubert

1 January 2013 in Bulletin de l'Académie Nationale de Médecine
Verified
Journal Article
Closed access
PDPatrice Debré
Patrice Debré
JGJean-Yves Le Gall
Jean-Yves Le Gall